;PMID: 8875708
;source_file_2961.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..43] = [t:0..43]
;1)sentence:[e:49..133] = [t:49..133]
;2)section:[e:137..147] = [t:137..147]
;3)section:[e:151..222] = [t:151..222]
;4)sentence:[e:226..453] = [t:226..453]
;5)sentence:[e:454..639] = [t:454..639]
;6)sentence:[e:640..760] = [t:640..760]
;7)sentence:[e:761..1009] = [t:761..1009]
;8)sentence:[e:1011..1201] = [t:1011..1201]
;9)sentence:[e:1202..1418] = [t:1202..1418]
;10)section:[e:1422..1474] = [t:1422..1474]
;11)section:[e:1478..1522] = [t:1478..1522]

;section 0 Span:0..43
;Semin Diagn Pathol.  1996 Aug;13(3):171-83.
(SEC
  (FRAG (NNP:[0..5] Semin) (NNP:[6..11] Diagn) (NNP:[12..18] Pathol)
        (.:[18..19] .) (CD:[21..25] 1996) (NNP:[26..29] Aug) (::[29..30] ;)
        (CD:[30..32] 13) (-LRB-:[32..33] -LRB-) (CD:[33..34] 3)
        (-RRB-:[34..35] -RRB-) (::[35..36] :) (CD:[36..42] 171-83)
        (.:[42..43] .)))

;sentence 1 Span:49..133
;Cytogenetics and tissue culture of small round cell tumors of bone and soft 
;tissue.
;[84..107]:malignancy-type:"small round cell tumors"
(SENT
  (NP-HLN
    (NP (NNS:[49..61] Cytogenetics))
    (CC:[62..65] and)
    (NP (NN:[66..72] tissue) (NN:[73..80] culture))
    (PP (IN:[81..83] of)
      (NP
        (NP
          (NP (JJ:[84..89] small) (JJ:[90..95] round) (NN:[96..100] cell)
              (NNS:[101..107] tumors))
          (PP (IN:[108..110] of)
            (NP (NN:[111..115] bone))))
        (CC:[116..119] and)
        (NP (JJ:[120..124] soft) (NN:[126..132] tissue))))
    (.:[132..133] .)))

;section 2 Span:137..147
;Noguera R.
(SEC
  (FRAG (NNP:[137..144] Noguera) (NNP:[145..146] R) (.:[146..147] .)))

;section 3 Span:151..222
;Department of Pathology, Medical School, University of Valencia, Spain.
(SEC
  (FRAG (NNP:[151..161] Department) (IN:[162..164] of)
        (NNP:[165..174] Pathology) (,:[174..175] ,) (NNP:[176..183] Medical)
        (NNP:[184..190] School) (,:[190..191] ,) (NNP:[192..202] University)
        (IN:[203..205] of) (NNP:[206..214] Valencia) (,:[214..215] ,)
        (NNP:[216..221] Spain) (.:[221..222] .)))

;sentence 4 Span:226..453
;The variety of tumor-specific cytogenetic and genetic alterations among small
; round cell tumors (Ewing family of tumors, rhabdomyosarcoma, neuroblastoma,
;and  lymphoma) increases the possibility of genotypic diagnosis of them.
;[298..322]:malignancy-type:"small  round cell tumors"
;[324..346]:malignancy-type:"Ewing family of tumors"
;[348..364]:malignancy-type:"rhabdomyosarcoma"
;[366..379]:malignancy-type:"neuroblastoma"
;[386..394]:malignancy-type:"lymphoma"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[226..229] The) (NN:[230..237] variety))
      (PP (IN:[238..240] of)
        (NP
          (NP
            (ADJP-1 (NN:[241..246] tumor) (HYPH:[246..247] -)
                    (JJ:[247..255] specific))
            (JJ:[256..267] cytogenetic)
            (NML-2 (-NONE-:[267..267] *P*)))
          (CC:[268..271] and)
          (NP
            (ADJP-1 (-NONE-:[271..271] *P*))
            (JJ:[272..279] genetic)
            (NML-2 (NNS:[280..291] alterations)))))
      (PP (IN:[292..297] among)
        (NP
           (JJ:[298..303] small) (JJ:[305..310] round) (NN:[311..315] cell)
           (NNS:[316..322] tumors)
          (PRN (-LRB-:[323..324] -LRB-)
            (NP
              (NP
                (NP (NNP:[324..329] Ewing) (NN:[330..336] family))
                (PP (IN:[337..339] of)
                  (NP (NNS:[340..346] tumors))))
              (,:[346..347] ,)
              (NP (NN:[348..364] rhabdomyosarcoma))
              (,:[364..365] ,)
              (NP (NN:[366..379] neuroblastoma))
              (,:[379..380] ,) (CC:[381..384] and)
              (NP (NN:[386..394] lymphoma)))
            (-RRB-:[394..395] -RRB-)))))
    (VP (VBZ:[396..405] increases)
      (NP
        (NP (DT:[406..409] the) (NN:[410..421] possibility))
        (PP (IN:[422..424] of)
          (NP
            (NP (JJ:[425..434] genotypic) (NN:[435..444] diagnosis))
            (PP (IN:[445..447] of)
              (NP (PRP:[448..452] them)))))))
    (.:[452..453] .)))

;sentence 5 Span:454..639
;In Ewing's  sarcoma and related peripheral primitive neuroectodermal tumors,
;a  (11;22)(q24;q12) translocation is associated with hybrid transcripts of
;the EWS  gene with the FLIl gene.
;[457..473]:malignancy-type:"Ewing's  sarcoma"
;[486..529]:malignancy-type:"peripheral primitive neuroectodermal tumors"
;[535..537]:variation-state-original:"11"
;[538..540]:variation-state-altered:"22"
;[542..545]:variation-state-original:"q24"
;[546..549]:variation-state-altered:"q12"
;[551..564]:malignancy-type:"translocation"
;[610..613]:gene-rna:"EWS"
;[629..633]:gene-rna:"FLIl"
(SENT
  (S
    (PP (IN:[454..456] In)
      (NP
        (NP
          (NP (NNP:[457..462] Ewing) (POS:[462..464] 's))
          (NN:[466..473] sarcoma))
        (CC:[474..477] and)
        (NP (VBN:[478..485] related)
           (JJ:[486..496] peripheral) (JJ:[497..506] primitive)
           (JJ:[507..522] neuroectodermal) (NNS:[523..529] tumors))))
    (,:[529..530] ,)
    (NP-SBJ-1 (DT:[531..532] a)
      (NML (-LRB-:[534..535] -LRB-) (CD:[535..537] 11) (::[537..538] ;)
           (CD:[538..540] 22) (-RRB-:[540..541] -RRB-))
      (NML (-LRB-:[541..542] -LRB-) (NN:[542..545] q24) (::[545..546] ;)
           (NN:[546..549] q12) (-RRB-:[549..550] -RRB-))
      (NN:[551..564] translocation))
    (VP (VBZ:[565..567] is)
      (VP (VBN:[568..578] associated)
        (NP-1 (-NONE-:[578..578] *))
        (PP-CLR (IN:[579..583] with)
          (NP
            (NP (JJ:[584..590] hybrid) (NNS:[591..602] transcripts))
            (PP (IN:[603..605] of)
              (NP (DT:[606..609] the) (NN:[610..613] EWS) (NN:[615..619] gene)))
            (PP (IN:[620..624] with)
              (NP (DT:[625..628] the) (NN:[629..633] FLIl) (NN:[634..638] gene)))))))
    (.:[638..639] .)))

;sentence 6 Span:640..760
;In alveolar rhabdomyosarcoma, a (2;13)(q35;qt4)  translocation is associated
;with a chimeric gene between PAX3 and FKHR.
;[643..668]:malignancy-type:"alveolar rhabdomyosarcoma"
;[673..674]:variation-state-original:"2"
;[675..677]:variation-state-altered:"13"
;[679..682]:variation-state-original:"q35"
;[683..686]:variation-state-altered:"qt4"
;[689..702]:variation-type:"translocation"
;[746..750]:gene-rna:"PAX3"
;[755..759]:gene-rna:"FKHR"
(SENT
  (S
    (PP (IN:[640..642] In)
      (NP (JJ:[643..651] alveolar) (NN:[652..668] rhabdomyosarcoma)))
    (,:[668..669] ,)
    (NP-SBJ-1 (DT:[670..671] a)
      (NML
        (NML (-LRB-:[672..673] -LRB-) (CD:[673..674] 2) (::[674..675] ;)
             (CD:[675..677] 13) (-RRB-:[677..678] -RRB-))
        (NML (-LRB-:[678..679] -LRB-) (NN:[679..682] q35) (::[682..683] ;)
             (NN:[683..686] qt4) (-RRB-:[686..687] -RRB-)))
      (NN:[689..702] translocation))
    (VP (VBZ:[703..705] is)
      (VP (VBN:[706..716] associated)
        (NP-1 (-NONE-:[716..716] *))
        (PP-CLR (IN:[717..721] with)
          (NP
            (NP (DT:[722..723] a) (JJ:[724..732] chimeric) (NN:[733..737] gene))
            (PP (IN:[738..745] between)
              (NP (NN:[746..750] PAX3) (CC:[751..754] and) (NN:[755..759] FKHR)))))))
    (.:[759..760] .)))

;sentence 7 Span:761..1009
;Specific  genetic alterations of the short arm of chromosome 1 and
;amplification of the  MYCN gene are diagnostically useful in neuroblastomas
;as the immunoglobulin or  T-cell receptor gene rearrangements and chromosome
;translocations in lymphomas.
;[771..790]:variation-event:"genetic alterations"
;[798..823]:variation-location:"short arm of chromosome 1"
;[828..841]:variation-type:"amplification"
;[850..854]:gene-rna:"MYCN"
;[889..903]:malignancy-type:"neuroblastomas"
;[911..925]:gene-rna:"immunoglobulin"
;[930..945]:gene-rna:"T-cell receptor"
;[951..965]:variation-type:"rearrangements"
;[981..995]:variation-type:"translocations"
;[999..1008]:malignancy-type:"lymphomas"
(SENT
  (S
    (NP-SBJ
      (NP
        (NP (JJ:[761..769] Specific)
           (JJ:[771..778] genetic) (NNS:[779..790] alterations))
        (PP (IN:[791..793] of)
          (NP
            (NP (DT:[794..797] the) (JJ:[798..803] short) (NN:[804..807] arm))
            (PP (IN:[808..810] of)
              (NP (NN:[811..821] chromosome) (CD:[822..823] 1))))))
      (CC:[824..827] and)
      (NP
        (NP (NN:[828..841] amplification))
        (PP (IN:[842..844] of)
          (NP (DT:[845..848] the) (NN:[850..854] MYCN) (NN:[855..859] gene)))))
    (VP (VBP:[860..863] are)
      (ADJP-PRD
        (ADVP (RB:[864..878] diagnostically))
        (JJ:[879..885] useful)
        (PP (IN:[886..888] in)
          (NP (NNS:[889..903] neuroblastomas)))
        (PP (IN:[904..906] as)
          (NP (DT:[907..910] the)
            (NML
              (NML
                (NML (NN:[911..925] immunoglobulin))
                (NML-1 (-NONE-:[925..925] *P*)))
              (CC:[926..928] or)
              (NML
                (NML (NN:[930..936] T-cell) (NN:[937..945] receptor))
                (NML-1 (NN:[946..950] gene) (NNS:[951..965] rearrangements))))))
        (CC:[966..969] and)
        (NP
          (NP (NN:[970..980] chromosome) (NNS:[981..995] translocations))
          (PP (IN:[996..998] in)
            (NP (NNS:[999..1008] lymphomas))))))
    (.:[1008..1009] .)))

;sentence 8 Span:1011..1201
;Thus, cytogenetics and genetics provide an essential adjunct to diagnostic 
;surgical pathology in the case of small round cell tumors, which often
;present  substantial diagnostic challenges.
;[1121..1144]:malignancy-type:"small round cell tumors"
(SENT
  (S
    (ADVP (RB:[1011..1015] Thus))
    (,:[1015..1016] ,)
    (NP-SBJ
      (NP (NNS:[1017..1029] cytogenetics))
      (CC:[1030..1033] and)
      (NP (NNS:[1034..1042] genetics)))
    (VP (VBP:[1043..1050] provide)
      (NP
        (NP (DT:[1051..1053] an) (JJ:[1054..1063] essential)
            (NN:[1064..1071] adjunct))
        (PP (TO:[1072..1074] to)
          (NP (JJ:[1075..1085] diagnostic) (JJ:[1087..1095] surgical)
              (NN:[1096..1105] pathology))))
      (PP (IN:[1106..1108] in)
        (NP
          (NP (DT:[1109..1112] the) (NN:[1113..1117] case))
          (PP (IN:[1118..1120] of)
            (NP
              (NP (JJ:[1121..1126] small) (JJ:[1127..1132] round)
                  (NN:[1133..1137] cell) (NNS:[1138..1144] tumors))
              (,:[1144..1145] ,)
              (SBAR
                (WHNP-1 (WDT:[1146..1151] which))
                (S
                  (NP-SBJ-1 (-NONE-:[1151..1151] *T*))
                  (ADVP-TMP (RB:[1152..1157] often))
                  (VP (VBP:[1158..1165] present)
                    (NP (JJ:[1167..1178] substantial)
                        (JJ:[1179..1189] diagnostic)
                        (NNS:[1190..1200] challenges))))))))))
    (.:[1200..1201] .)))

;sentence 9 Span:1202..1418
;Likewise, in vitro culture studies represent  another approach in determining
;histogenetic origin, novel genes, novel  mechanisms of gene dysregulation,
;and the biological characteristics of small  round cell tumors.
;[1393..1417]:malignancy-type:"small  round cell tumors"
(SENT
  (S
    (ADVP (RB:[1202..1210] Likewise))
    (,:[1210..1211] ,)
    (NP-SBJ
      (ADJP (FW:[1212..1214] in) (FW:[1215..1220] vitro))
      (NN:[1221..1228] culture) (NNS:[1229..1236] studies))
    (VP (VBP:[1237..1246] represent)
      (NP (DT:[1248..1255] another) (NN:[1256..1264] approach))
      (PP (IN:[1265..1267] in)
        (S-NOM
          (NP-SBJ (-NONE-:[1267..1267] *))
          (VP (VBG:[1268..1279] determining)
            (NP
              (NP (JJ:[1280..1292] histogenetic) (NN:[1293..1299] origin))
              (,:[1299..1300] ,)
              (NP (JJ:[1301..1306] novel) (NNS:[1307..1312] genes))
              (,:[1312..1313] ,)
              (NP
                (NP (JJ:[1314..1319] novel) (NNS:[1321..1331] mechanisms))
                (PP (IN:[1332..1334] of)
                  (NP (NN:[1335..1339] gene) (NN:[1340..1353] dysregulation))))
              (,:[1353..1354] ,) (CC:[1355..1358] and)
              (NP
                (NP (DT:[1359..1362] the) (JJ:[1363..1373] biological)
                    (NNS:[1374..1389] characteristics))
                (PP (IN:[1390..1392] of)
                  (NP (JJ:[1393..1398] small) (JJ:[1400..1405] round)
                      (NN:[1406..1410] cell) (NNS:[1411..1417] tumors)))))))))
    (.:[1417..1418] .)))

;section 10 Span:1422..1474
;Publication Types:      Review      Review, Tutorial
(SEC
  (FRAG (NNP:[1422..1433] Publication) (NNP:[1434..1439] Types)
        (::[1439..1440] :) (NNP:[1446..1452] Review) (NNP:[1458..1464] Review)
        (,:[1464..1465] ,) (NNP:[1466..1474] Tutorial)))

;section 11 Span:1478..1522
;PMID: 8875708 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1478..1482] PMID) (::[1482..1483] :) (CD:[1484..1491] 8875708)
        (NN:[1492..1493] -LSB-) (NNP:[1493..1499] PubMed) (::[1500..1501] -)
        (NN:[1502..1509] indexed) (IN:[1510..1513] for)
        (NNP:[1514..1521] MEDLINE) (-RRB-:[1521..1522] -RSB-)))
